Skip to main content

Table 2 Median OPN plasma levels (ng/ml±SD) before (t0), at the end (t1) and four weeks after radiotherapy (t2) in curative-intent, palliative-intent and all patient (p- values refer to difference between curative and palliative cohort)

From: Prognostic information of serial plasma osteopontin measurement in radiotherapy of non-small-cell lung cancer

 

Curative (M0)

N

Palliative (M1)

N

All (M0+M1)

N

P

t0

816.6 (±430)

55

1279.6 (±1125)

14

879.6 (±674.3)

69

< .0001

t1

789.3 (±373.8)

52

1068.7 (±1487)

12

811.1 (±787.7)

64

< .0001

t2

674.5 (±547.2)

43

1238 (±1529.4)

6

703.4 (±787.7)

49

< .0001

t0 to t1*

-6.4 (±62.4)

52

+6 (61.6)

12

-3.7 (±62)

64

.979

t1 to t2*

-5.2 (±55.7)

41

-19.9 (±94.1)

5

-5.2 (±59.6)

46

.963

  1. *median relative changes in %.